Nicola Scichilone Selected Research

Respiratory Therapy (Therapy, Respiratory)

1/2020	Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler.
1/2020	Airway Deposition of Extrafine Inhaled Triple Therapy in Patients with COPD: A Model Approach Based on Functional Respiratory Imaging Computer Simulations.
1/2018	Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD.
1/2013	Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations.
1/2013	Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola Scichilone Research Topics

Disease

56	Asthma (Bronchial Asthma) 08/2022 - 03/2004
30	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 06/2004
11	Inflammation (Inflammations) 04/2022 - 03/2008
5	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020 - 01/2014
4	COVID-19 05/2022 - 12/2020
4	Hypersensitivity (Allergy) 10/2021 - 01/2011
3	Dyspnea (Shortness of Breath) 05/2022 - 01/2015
3	Bronchiectasis 01/2022 - 01/2014
2	Rhinosinusitis 12/2021 - 01/2018
2	Allergic Rhinitis 10/2021 - 02/2011
2	Anaphylaxis (Anaphylactic Shock) 10/2021 - 01/2015
2	Infections 01/2021 - 01/2020
2	Eosinophilia 01/2021 - 01/2016
2	Lung Diseases (Lung Disease) 12/2020 - 01/2014
2	Airway Obstruction (Choking) 01/2020 - 06/2004
2	Systemic Scleroderma (Systemic Sclerosis) 04/2018 - 01/2008
2	Cognitive Dysfunction 03/2016 - 01/2014
1	Respiratory Insufficiency (Respiratory Failure) 05/2022
1	Pleural Effusion (Pleural Effusions) 05/2022
1	Bradycardia 03/2022
1	Nasal Polyps (Nasal Polyp) 12/2021
1	Fever (Fevers) 01/2021
1	Hemoptysis 01/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Cataract (Cataracts) 01/2020
1	Oral Candidiasis (Thrush) 01/2020
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2020
1	Osteoporosis 01/2020
1	Peptic Ulcer (Peptic Ulcers) 01/2020
1	Dysphonia (Spastic Dysphonia) 01/2020
1	Idiopathic Pulmonary Fibrosis 01/2020
1	Human Influenza (Influenza) 10/2019
1	Albuminuria 10/2019

Drug/Important Bio-Agent (IBA)

26	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 09/2005
11	Pharmaceutical PreparationsIBA 03/2022 - 01/2013
11	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 04/2003
8	Formoterol Fumarate (Oxis)FDA Link 01/2020 - 10/2008
7	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2016
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 03/2008
6	GoldIBA 01/2020 - 09/2008
6	Methacholine Chloride (Methacholine)FDA Link 11/2012 - 06/2004
5	mepolizumabIBA 04/2022 - 11/2019
5	Biological ProductsIBA 04/2022 - 01/2018
5	benralizumabIBA 04/2022 - 11/2019
5	Muscarinic AntagonistsIBA 01/2022 - 01/2016
5	Omalizumab (Xolair)FDA Link 01/2021 - 01/2017
4	Beclomethasone (Beclometasone)FDA Link 01/2020 - 10/2008
3	Immunoglobulin E (IgE)IBA 04/2022 - 01/2021
3	Fluticasone (Cutivate)FDA LinkGeneric 01/2022 - 09/2005
3	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2021 - 01/2016
3	SteroidsIBA 01/2020 - 09/2005
3	VaccinesIBA 10/2019 - 01/2011
3	Cholinergic Antagonists (Anticholinergics)IBA 01/2019 - 01/2016
3	Budesonide (Pulmicort)FDA LinkGeneric 01/2017 - 02/2011
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2022 - 01/2020
2	AerosolsIBA 01/2021 - 12/2020
2	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2021 - 01/2017
2	Therapeutic UsesIBA 01/2021 - 10/2008
2	reslizumabIBA 11/2019 - 01/2018
2	Oxygen (Dioxygen)IBA 01/2019 - 01/2014
2	oxidized low density lipoproteinIBA 01/2018 - 12/2013
2	LDL Lipoproteins (beta Lipoproteins)IBA 07/2015 - 12/2013
2	monophosphoryl lipid AIBA 08/2013 - 01/2011
2	prednylidene (Pred)IBA 04/2013 - 09/2012
2	montelukast (Singulair)FDA Link 01/2013 - 03/2008
1	Proteins (Proteins, Gene)FDA Link 05/2022
1	remdesivirIBA 03/2022
1	Mometasone Furoate (Nasonex)FDA LinkGeneric 01/2022
1	AllergensIBA 01/2022
1	indacaterolIBA 01/2022
1	Salmeterol Xinafoate (Serevent)FDA Link 01/2022
1	COVID-19 VaccinesIBA 10/2021
1	proadrenomedullinIBA 09/2021
1	Surface-Active Agents (Surfactants)IBA 01/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 01/2021
1	dupilumabIBA 01/2021
1	Prednisone (Sone)FDA LinkGeneric 01/2021
1	nintedanibIBA 01/2021
1	anti-IgE antibodiesIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	GSK573719IBA 01/2020
1	fluticasone furoate FDA Link 01/2020
1	Interleukin-5 (Interleukin 5)IBA 01/2020
1	vilanterolIBA 01/2020
1	GlucocorticoidsIBA 11/2019
1	Nicotine FDA Link 10/2019

Therapy/Procedure

25	Therapeutics 08/2022 - 03/2004
10	Nebulizers and Vaporizers (Inhaler) 08/2022 - 06/2011
5	Respiratory Therapy (Therapy, Respiratory) 01/2020 - 01/2013
2	Injections 10/2021 - 08/2013
2	Length of Stay 03/2021 - 01/2016
1	Transjugular Intrahepatic Portasystemic Shunt 01/2022
1	Electronic Nose 12/2021
1	Artificial Respiration (Mechanical Ventilation) 09/2021
1	Biological Therapy 01/2021
1	Contraindications 01/2020
1	Traction 01/2020
1	Drug Therapy (Chemotherapy) 01/2020